Agree. Yuman is certainly being acknowledged in many ways at the moment. He seems to be involved across several parts that are now coming together like a jig saw puzzle. All parts seem to safe, effective and lower cost.. The way this is heading he must be on a short list for a Noble Prize if/when his ambition is eventually realised through IMU and its partners. He certainly deserves it.
Ann: Imugene and Eureka Therapeutics onCARlytics Collaboration, page-18
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.004(7.41%) |
Mkt cap ! $422.5M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $905.1K | 15.96M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 1881514 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 1937690 | 24 |
View Market Depth
| Last trade - 14.21pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |